# Do You Have a Study or Source Correction?

> Contact Swe Peptider About a Study or Source — Contact Swe Peptider about a source or new study on Metabolic & Weight Research peptides, meaning compounds studied for body fuel and weight.

**SOURCE FIXES AND NEW STUDIES**

Send the page, the words that need checking, and the source. A written note lets the editor check each fact.

## What belongs in an email to the editor?

Write if a source was quoted wrong or a trial has new results. A changed approval or new study on MOTS-c, semaglutide, or tesamorelin also belongs here.

Each note is checked against the [references page](/references). Email keeps the source beside the words that may need a change.

Give the page name and quote the exact passage in question. Include the paper or public record that supports your note.

A DOI is a paper’s lasting file number. PubMed is a government-run web library for medical papers, and its paper number also helps.

The editor reads the full source before any words change. **Editorial mailbox:** editors@swepeptider.com

## Which questions can’t the editor answer about your care?

Swe Peptider cannot tell you to use a compound or help you find one. The editor also cannot give a dose, schedule, or way to take it.

A study result may not fit your age, health, or other medicine. Only a local health worker who knows your case can weigh those facts.

Semaglutide and tesamorelin are prescription drugs for approved uses. MOTS-c has no approved human use of any kind.

Send source questions to the mailbox, but do not rely on it for care. Messages are read as time permits, and some will not receive a reply.

---

An independent audit of the metabolic-peptide literature that says plainly what's proven, what's preliminary, and what's still guesswork.